These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6006623)

  • 1. [An anti-phlogistic effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine) on experimentally induced ocular inflammation].
    Asayama R; Tsukahara I; Sakaue E; Fukuchi S; Suga K
    Nihon Ganka Kiyo; 1966 Feb; 17(2):89-101. PubMed ID: 6006623
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical study on anti-inflammatory effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine)].
    Asayama R; Tsukahara I; Sakaue E; Fukuchi S; Suga K
    Nihon Ganka Kiyo; 1966 Feb; 17(2):102-6. PubMed ID: 6006605
    [No Abstract]   [Full Text] [Related]  

  • 3. [On antiphlogistic effect of BCP].
    Mine T; Asayama T; Tsuboi T; Hata S; Yamada H
    Nippon Ganka Gakkai Zasshi; 1966 Nov; 70(11):1840-55. PubMed ID: 6009662
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the ocular anti-inflammatory activity of steroidal and nonsteroidal compounds in the rat.
    Bhattacherjee P; Williams RN; Eakins KE
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1143-6. PubMed ID: 6874278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological studies on 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) as an anti-inflammatory agent].
    Fujimura H; Tsurumi A; Hayashi M; Ushijima M; Esaki S
    Nihon Yakurigaku Zasshi; 1967 Mar; 63(2):43-86. PubMed ID: 6069249
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 5-n-butyl-l-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) on antibody formation].
    Kondo M; Tsuchiya K
    Nihon Saikingaku Zasshi; 1966 Oct; 21(10):629-32. PubMed ID: 6009584
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dimethyl sulfoxide on ocular inflammation.
    Hanna C; Fraunfelder FT; Meyer SM
    Ann Ophthalmol; 1977 Jan; 9(1):61-5. PubMed ID: 319730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye.
    Rafie F; Javadzadeh Y; Javadzadeh AR; Ghavidel LA; Jafari B; Moogooee M; Davaran S
    Curr Eye Res; 2010 Dec; 35(12):1081-9. PubMed ID: 20961207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-steroidal anti-inflammatory drugs for eye diseases].
    Kimura S
    Ganka; 1968 Dec; 10(12):868-80. PubMed ID: 4887254
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. II. Determination of BCP and its metabolite, 1-cyclohexyl-5-(3-hydroxybutyl)-2,4,6-trioxoperhydropyrimidine by ultraviolet absorption method.
    Yashiki T; Kondo T; Uda Y; Mima H
    Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):478-86. PubMed ID: 5553047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 5-n-butyl-l-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) on bacterial infection].
    Kondo M; Yamasaki T; Tsuchiya K
    Nihon Saikingaku Zasshi; 1966 Dec; 21(12):715-8. PubMed ID: 6010440
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxicity of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP)].
    Tanabe K; Takaori S; Shimamoto K
    Nihon Yakurigaku Zasshi; 1967 May; 63(3):105-22. PubMed ID: 6069762
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative effect of topically applied anti-inflammatory agents on external ocular inflammation in rats.
    Maistrello I; Rigamonti G; Frova C; De Ruggieri P
    J Pharm Sci; 1973 Sep; 62(9):1455-60. PubMed ID: 4743091
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiphlogistic effect of a combination of dexamethasone, pyrazolone and vitamin B 12].
    Feyen H; Hiemeyer V
    Arzneimittelforschung; 1971 Jan; 21(1):39-40. PubMed ID: 5313891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibitory effect of non-steroidal anti-inflammatory agents on experimentally induced uveitis and a clinical use of non-steroidal anti-inflammatory agents].
    Mishima K; Shirai A; Hara J; Yamashita S
    Nihon Ganka Kiyo; 1968 Oct; 19(10):978-87. PubMed ID: 4885032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of a new corticosteroid in some aspecific inflammatory ocular diseases: dexamethasone 21-(pyridine-4-carboxylate)].
    Balestrazzi E; Scorcia G; Ranieri G
    Ann Ottalmol Clin Ocul; 1971 Jan; 97(1):15-22. PubMed ID: 5122645
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. 3. Gas-liquid chromatographic determination of BCP and its metabolites.
    Yashiki T; Uda Y; Kondo T; Mima H
    Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):487-92. PubMed ID: 5553048
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis.
    Graham RO; Peyman GA
    Arch Ophthalmol; 1974 Aug; 92(2):149-54. PubMed ID: 4211214
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system.
    Taniguchi K; Itakura K; Yamazawa N; Morisaki K; Hayashi S; Yamada Y
    J Pharmacobiodyn; 1988 Jan; 11(1):39-46. PubMed ID: 3385602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. I. Identification of the metabolites of BCP in human urine.
    Yashiki T; Matsuzawa T; Kondo T; Uda Y; Shima T
    Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):468-77. PubMed ID: 5553046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.